DIPENTAERYTHRITOL
General Information
Mainterm | DIPENTAERYTHRITOL |
CAS Reg.No.(or other ID) | 126-58-9 |
Regnum |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 31352 |
IUPAC Name | 2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methyl]-2-(hydroxymethyl)propane-1,3-diol |
InChI | InChI=1S/C10H22O7/c11-1-9(2-12,3-13)7-17-8-10(4-14,5-15)6-16/h11-16H,1-8H2 |
InChI Key | TXBCBTDQIULDIA-UHFFFAOYSA-N |
Canonical SMILES | C(C(CO)(CO)COCC(CO)(CO)CO)O |
Molecular Formula | C10H22O7 |
Wikipedia | dipentaerythritol |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 254.279 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 10 |
Complexity | 153.0 |
CACTVS Substructure Key Fingerprint | A A A D c e B w O A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A G g A A C A A A D g C g g A I A A A A A B g A A A A A A A A A A A A A A A A A A A A A A A A A A E A A A A A A C Q A A B A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 131.0 |
Monoisotopic Mass | 254.137 |
Exact Mass | 254.137 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 17 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.8052 |
Human Intestinal Absorption | HIA+ | 0.8922 |
Caco-2 Permeability | Caco2- | 0.6384 |
P-glycoprotein Substrate | Non-substrate | 0.6479 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9146 |
Non-inhibitor | 0.6280 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.8801 |
Distribution | ||
Subcellular localization | Mitochondria | 0.5555 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8795 |
CYP450 2D6 Substrate | Non-substrate | 0.8896 |
CYP450 3A4 Substrate | Non-substrate | 0.7597 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8632 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8874 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9391 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8164 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9277 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9393 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9465 |
Non-inhibitor | 0.9437 | |
AMES Toxicity | Non AMES toxic | 0.8057 |
Carcinogens | Non-carcinogens | 0.5958 |
Fish Toxicity | Low FHMT | 0.8922 |
Tetrahymena Pyriformis Toxicity | Low TPT | 0.9719 |
Honey Bee Toxicity | High HBT | 0.7695 |
Biodegradation | Not ready biodegradable | 0.8541 |
Acute Oral Toxicity | III | 0.5858 |
Carcinogenicity (Three-class) | Non-required | 0.6335 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | 0.1989 | LogS |
Caco-2 Permeability | 0.2913 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 1.2486 | LD50, mol/kg |
Fish Toxicity | 3.0491 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | -1.5885 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Organic oxygen compounds |
Class | Organooxygen compounds |
Subclass | Ethers |
Intermediate Tree Nodes | Not available |
Direct Parent | Dialkyl ethers |
Alternative Parents | |
Molecular Framework | Aliphatic acyclic compounds |
Substituents | Dialkyl ether - Hydrocarbon derivative - Primary alcohol - Alcohol - Aliphatic acyclic compound |
Description | This compound belongs to the class of organic compounds known as dialkyl ethers. These are organic compounds containing the dialkyl ether functional group, with the formula ROR', where R and R' are alkyl groups. |
From ClassyFire